Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sundell

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1993
Insulin and IGF-I analogs: novel approaches to improved insulin pharmacokineticsL J Slieker, G S Brooke, R E Chance, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 8, 2019
Magnetic resonance imaging measures of brain atrophy from the EXPEDITION3 trial in mild Alzheimer's diseaseAdam J Schwarz, Karen L Sundell, Arnaud Charil, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 3, 2017
Use of white matter reference regions for detection of change in florbetapir positron emission tomography from completed phase 3 solanezumab trialsAdam S Fleisher, Abhinay D Joshi, Karen L Sundell, et al.
Transplantation|July 9, 2004
Effects of AGI-1096, a novel antioxidant compound with anti-inflammatory and antiproliferative properties, on rodent allograft arteriosclerosisSeiichiro Murata, Cynthia L Sundell, Maarten A Lijkwan, et al.
Diabetologia|July 1, 1997
Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptorL J Slieker, G S Brooke, R D DiMarchi, et al.
Journal of Medicinal Chemistry|February 28, 2007
Carboxylated, heteroaryl-substituted chalcones as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseasesCharles Q Meng, Liming Ni, Kimberly J Worsencroft, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosisCharles Q Meng, Patricia K Somers, Carolyn L Rachita, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 11, 2003
AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agentCynthia L Sundell, Patricia K Somers, Charles Q Meng, et al.
Clinical Lung Cancer|November 24, 2004
Expression levels of protein kinase C-alpha in non-small-cell lung cancerMichael Lahn, Chen Su, Shuyu Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 11, 2005
AGIX-4207 [2-[4-[[1-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]thio]-1-methylethyl]thio]-2,6-bis(1,1-dimethylethyl)phenoxy]acetic acid], a novel antioxidant and anti-inflammatory compound: cellular and biochemical characterization of antioxidant activity and inhibition of redox-sensitive inflammatory gene expressionCharles Kunsch, Jayraz Luchoomun, Xi-Lin Chen, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Advances in Experimental Medicine and Biology|January 1, 1993
Insulin and IGF-I analogs: novel approaches to improved insulin pharmacokineticsL J Slieker, G S Brooke, R E Chance, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 8, 2019
Magnetic resonance imaging measures of brain atrophy from the EXPEDITION3 trial in mild Alzheimer's diseaseAdam J Schwarz, Karen L Sundell, Arnaud Charil, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 3, 2017
Use of white matter reference regions for detection of change in florbetapir positron emission tomography from completed phase 3 solanezumab trialsAdam S Fleisher, Abhinay D Joshi, Karen L Sundell, et al.
Transplantation|July 9, 2004
Effects of AGI-1096, a novel antioxidant compound with anti-inflammatory and antiproliferative properties, on rodent allograft arteriosclerosisSeiichiro Murata, Cynthia L Sundell, Maarten A Lijkwan, et al.
Diabetologia|July 1, 1997
Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptorL J Slieker, G S Brooke, R D DiMarchi, et al.
Journal of Medicinal Chemistry|February 28, 2007
Carboxylated, heteroaryl-substituted chalcones as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseasesCharles Q Meng, Liming Ni, Kimberly J Worsencroft, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosisCharles Q Meng, Patricia K Somers, Carolyn L Rachita, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 11, 2003
AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agentCynthia L Sundell, Patricia K Somers, Charles Q Meng, et al.
Clinical Lung Cancer|November 24, 2004
Expression levels of protein kinase C-alpha in non-small-cell lung cancerMichael Lahn, Chen Su, Shuyu Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 11, 2005
AGIX-4207 [2-[4-[[1-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]thio]-1-methylethyl]thio]-2,6-bis(1,1-dimethylethyl)phenoxy]acetic acid], a novel antioxidant and anti-inflammatory compound: cellular and biochemical characterization of antioxidant activity and inhibition of redox-sensitive inflammatory gene expressionCharles Kunsch, Jayraz Luchoomun, Xi-Lin Chen, et al.
Pageof 7